Faculty, Staff and Student Publications
Language
English
Publication Date
1-21-2026
Journal
Nature Communications
DOI
10.1038/s41467-026-68522-0
PMID
41559081
PMCID
PMC12916934
PubMedCentral® Posted Date
1-21-2026
PubMedCentral® Full Text Version
Post-print
Abstract
Aromatase inhibitors are widely used in the treatment of hormone-sensitive breast cancer, but their suppression of estrogen production accelerates bone loss, increases fracture risk, and negatively impacts muscle and fat metabolism. Here, we demonstrate that daily low intensity vibration, serving as a non-drug mimetic for exercise, protects musculoskeletal health in skeletally immature, female mice under complete estrogen deprivation. Subsequent improvements in vertebral bone density are paralleled by greater and leaner skeletal muscle mass and function alongside reduced fat accretion and circulating metabolites. In mature, estrogen deprived mice, vibration enhances weekly bisphosphonate treatment, improving bone density, cortical thickness, and mechanical resistance to fracture. These findings support the proposed hypothesis that low intensity vibration reduces musculoskeletal frailty in estrogen deprived mice, with stronger effects observed in younger cohorts, while in skeletally mature mice combination therapy with anti-resorptive treatment is necessary to suppress cancer-treatment induced musculoskeletal degradation.
Keywords
Animals, Female, Vibration, Estrogens, Zoledronic Acid, Mice, Muscle, Skeletal, Adiposity, Bone Density, Mice, Inbred C57BL, Bone Density Conservation Agents, Muscle Weakness, Bone metastases, Breast cancer, Translational research
Published Open-Access
yes
Recommended Citation
Pagnotti, Gabriel M; Trivedi, Trupti; Wright, Laura E; et al., "Low Intensity Vibration With Zoledronate Reduces Musculoskeletal Weakness and Adiposity in Estrogen Deprived Female Mice" (2026). Faculty, Staff and Student Publications. 5789.
https://digitalcommons.library.tmc.edu/uthgsbs_docs/5789
Included in
Bioinformatics Commons, Biomedical Informatics Commons, Genetic Phenomena Commons, Medical Genetics Commons, Oncology Commons